BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 10545490)

  • 1. mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells.
    Guermonprez P; Lo-Man R; Sedlik C; Rojas MJ; Poljak RJ; Leclerc C
    Int Immunol; 1999 Nov; 11(11):1863-72. PubMed ID: 10545490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
    Rosloniec EF; Gay D; Freed JH
    J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
    J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of dissociation between antibody and antigen determines the efficiency of antibody-mediated antigen presentation to T cells.
    Guermonprez P; England P; Bedouelle H; Leclerc C
    J Immunol; 1998 Nov; 161(9):4542-8. PubMed ID: 9794380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
    Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
    J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells.
    Herzog J; Maekawa Y; Cirrito TP; Illian BS; Unanue ER
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7928-33. PubMed ID: 15901898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
    Moreno J; Adorini L; Hämmerling GJ
    J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
    Kanost D; Basten A; McCluskey J
    Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
    Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
    J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.
    Bonifaz LC; Arzate S; Moreno J
    Eur J Immunol; 1999 Jan; 29(1):119-31. PubMed ID: 9933093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing and presentation of hen egg-white lysozyme by macrophages.
    Allen PM; Unanue ER
    Immunobiology; 1984 Dec; 168(3-5):182-8. PubMed ID: 6085068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DM determines the cryptic and immunodominant fate of T cell epitopes.
    Nanda NK; Sant AJ
    J Exp Med; 2000 Sep; 192(6):781-8. PubMed ID: 10993909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
    Brooks AG; McCluskey J
    J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell epitope recognition involved in the low-responsiveness to a region of hen egg lysozyme (46-61) in C57BL/6 mice.
    Jang YS; Mikszta JA; Kim BS
    Mol Immunol; 1994 Aug; 31(11):803-12. PubMed ID: 7519304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.